Prevalence and Risk Factors of Chronic Kidney Disease Among Patients with Type 2 Diabetes Mellitus at a Tertiary Care Hospital in Nepal: a Cross-sectional Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2023 Feb 28

PMID 36854582

Authors

Rinku Joshi

Prativa Subedi

Gopal Kumar Yadav

Sitaram Khadka

Thaneshwar Rijal

Kapil Amgain

Sabin Rajbhandari

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the prevalence of chronic kidney disease (CKD) among patients with type 2 diabetes mellitus (T2DM) and determine the sociodemographic and clinical risk factors associated with CKD.

Design And Settings: Cross-sectional study among diabetic outpatients of a tertiary hospital in Nepal.

Participants: 201 patients with T2DM above 18 years of age.

Intervention: Participants completed a questionnaire regarding their socioeconomic information and underwent pertinent physical and haematological examinations.

Primary And Secondary Outcomes Measure: The prevalence and risk factors of CKD among patients with T2DM.

Results: The prevalence of CKD in T2DM was 86.6%. In univariable analysis, the variables like age (p=0.026), hypertension status (p=0.002), duration of diabetes (p=0.009) and haemoglobin levels (p=0.027) were significantly associated with CKD among the participants with T2DM. Kruskal-Wallis H test showed that age was significantly different between various CKD stages. Multivariate analysis demonstrated a significant relationship between CKD with age (Adjusted odds ratio (AOR) 3, 95% CI 1.1 to 8.8) and literacy status (AOR 5.8, 95% CI 1.4 to 24.6) CONCLUSION: Advancing age, concomitant hypertension, increasing duration of T2DM and presence of anaemia were found to be important risk factors of CKD. Age is the most important predictor of CKD showing increasing prevalence in the elderly population. Periodic screening tests are essential at an early age to identify kidney diseases at incipient stages, thereby preventing progression to end-stage renal disease.

Citing Articles

Prevalence of chronic kidney disease and associated factors among adult diabetic patients: a hospital-based cross-sectional study.

Aregawi K, Kabew Mekonnen G, Belete R, Kucha W Front Epidemiol. 2024; 4:1467911.

PMID: 39628978 PMC: 11611590. DOI: 10.3389/fepid.2024.1467911.

Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?.

Zywno H, Figiel W, Grat M, Nazarewski S, Galazka Z, Malyszko J Int J Mol Sci. 2024; 25(22).

PMID: 39596140 PMC: 11593440. DOI: 10.3390/ijms252212072.

Nutritional Risk Factors in Albuminuria and Retinopathy in Patients Newly Diagnosed With Type 2 Diabetes: A Cross-sectional Case Series Study.

Arimura E, Maruguti Y, Nakao Y, Ushikai M, Yotsueda K, Kajiya S In Vivo. 2024; 38(5):2506-2514.

PMID: 39187356 PMC: 11363750. DOI: 10.21873/invivo.13722.

Prevalence of chronic kidney disease in Tunisian diabetics: the TUN-CKDD survey.

Labidi J, Harzallah A, Kaab B, Mami I, Agrebi S, Azzabi A BMC Nephrol. 2024; 25(1):67.

PMID: 38403649 PMC: 10895808. DOI: 10.1186/s12882-024-03501-5.

[Exploring facilitators and barriers to implementing expanded nursing roles in MexicoEstudo de facilitadores e barreiras para a implementação de funções ampliadas de enfermagem no México].

Casales-Hernandez M, Reyes-Morales H, Nigenda G, Garcia-Saiso S Rev Panam Salud Publica. 2023; 47:e142.

PMID: 38024445 PMC: 10648440. DOI: 10.26633/RPSP.2023.142.

References

Ferreira J, Girerd N, Pellicori P, Duarte K, Girerd S, Pfeffer M . Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk.... BMC Med. 2016; 14(1):181. PMC: 5103492. DOI: 10.1186/s12916-016-0731-2. View

Unnikrishnan R, Rema M, Pradeepa R, Deepa M, Shanthirani C, Deepa R . Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care. 2007; 30(8):2019-24. DOI: 10.2337/dc06-2554. View

Alrawahi A, Rizvi S, Al-Riyami D, Al-Anqoodi Z . Prevalence and risk factors of diabetic nephropathy in omani type 2 diabetics in Al-dakhiliyah region. Oman Med J. 2012; 27(3):212-6. PMC: 3394354. DOI: 10.5001/omj.2012.48. View

Mehdi U, Toto R . Anemia, diabetes, and chronic kidney disease. Diabetes Care. 2009; 32(7):1320-6. PMC: 2699743. DOI: 10.2337/dc08-0779. View

Luk A, Ma R, Lau E, Yang X, Lau W, Yu L . Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2013; 29(5):384-90. DOI: 10.1002/dmrr.2404. View

Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J . Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?. Nephrol Dial Transplant. 2014; 29(12):2167-77. DOI: 10.1093/ndt/gfu006. View

Stevens L, Viswanathan G, Weiner D . Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010; 17(4):293-301. PMC: 3160131. DOI: 10.1053/j.ackd.2010.03.010. View

Selby N, Taal M . An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020; 22 Suppl 1:3-15. DOI: 10.1111/dom.14007. View

Kawazu S, Tomono S, Shimizu M, Kato N, Ohno T, Ishii C . The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications. 1994; 8(1):13-7. DOI: 10.1016/1056-8727(94)90005-1. View

10.

Chudek J, Wieczorowska-Tobis K, Zejda J, Broczek K, Skalska A, Zdrojewski T . The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study PolSenior. Nephrol Dial Transplant. 2013; 29(5):1073-82. DOI: 10.1093/ndt/gft351. View

11.

Koye D, Magliano D, Nelson R, Pavkov M . The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis. 2018; 25(2):121-132. PMC: 11000253. DOI: 10.1053/j.ackd.2017.10.011. View

12.

Janmohamed M, Kalluvya S, Mueller A, Kabangila R, Smart L, Downs J . Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol. 2013; 14:183. PMC: 3765892. DOI: 10.1186/1471-2369-14-183. View

13.

Low S, Sum C, Yeoh L, Tavintharan S, Ng X, Lee S . Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus. Ann Acad Med Singap. 2015; 44(5):164-71. View

14.

Strippoli G, Bonifati C, Craig M, Navaneethan S, Craig J . Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006; (4):CD006257. PMC: 6956646. DOI: 10.1002/14651858.CD006257. View

15.

New J, Aung T, Baker P, Yongsheng G, Pylypczuk R, Houghton J . The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med. 2008; 25(5):564-9. DOI: 10.1111/j.1464-5491.2008.02424.x. View

16.

Hall M, do Carmo J, da Silva A, Juncos L, Wang Z, Hall J . Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014; 7:75-88. PMC: 3933708. DOI: 10.2147/IJNRD.S39739. View

17.

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K . Microvascular Complications of Type 2 Diabetes Mellitus. Curr Vasc Pharmacol. 2019; 18(2):117-124. DOI: 10.2174/1570161117666190502103733. View

18.

Busch M, Franke S, Ruster C, Wolf G . Advanced glycation end-products and the kidney. Eur J Clin Invest. 2010; 40(8):742-55. DOI: 10.1111/j.1365-2362.2010.02317.x. View

19.

Carrero J, Hecking M, Chesnaye N, Jager K . Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018; 14(3):151-164. DOI: 10.1038/nrneph.2017.181. View

20.

Weinstein J, Anderson S . The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010; 17(4):302-7. PMC: 2901622. DOI: 10.1053/j.ackd.2010.05.002. View